HOME > BUSINESS > Article

Text Size

small

medium

large


Takeda Completes Acquisition of U.S. Drug Maker Ariad

Takeda Completes Acquisition of U.S. Drug Maker Ariad

   Tokyo, Feb. 17 (Jiji Press)--Japan's Takeda Pharmaceutical Co. <4502> said Friday that it has completed the 5.4-billion-dollar acquisition of U.S. industry peer Ariad Pharmaceuticals Inc.
   The acquisition "strengthens and diversifies our oncology business, positioning Takeda for sustainable long-term growth in this priority therapeutic area," Takeda President Christophe Weber said in a statement.

To read a full story, please click here to find out how to subscribe.

BUSINESS

HEADLINES

POLITICS
Japan PM Abe Seen Adding Italy to March European Tour on Top of France, Germany
ECONOMY
Japan Govt Lowers Assessment on Personal Consumption for First Time in 11 Months
SPORTS
Japan National Team Starts Practicing for World Baseball Classic in March
OTHER
Japan Govt Panel of Experts Proposes Designation of 14 Invasive Alien Species

AFP-JIJI PRESS NEWS JOURNAL


Photos